Evidence-based supplements, vitamins, minerals, nootropics, and longevity interventions
217 artigos
A riboflavina (vitamina B2) inibe o crescimento de *Cryptococcus neoformans*, desestrutura biofilmes e reduz a carga fúngica em órgãos em modelos murinos de meningite e pneumonia.
Análises de especialistas confirmam que NR e NMN elevam o NAD+ no sangue, mas as evidências de longevidade permanecem inconclusivas e a qualidade dos produtos varia amplamente.
A JAMA viewpoint exposes how illicit injectable peptides are escaping regulation as the line between medicine and enhancement blurs.
Dr. Abud Bakri covers BPC-157, epithalon, GHK-Cu, GLP-1s, and growth hormone peptides — separating real evidence from hype.
Both NMN and NR raise NAD+ levels in humans, but clinical proof of anti-aging benefits is still lacking — and product quality varies widely.
Attia lays out a rigorous, personalized decision framework for evaluating medications and supplements — cutting through hype with evidence hierarchy and risk math.
A candid breakdown of top NAD+ booster brands reveals strong biomarker data but slim evidence for real longevity outcomes.
A double-blind RCT finds daily spermidine supplementation reverses immune senescence markers and boosts vaccine antibody responses in adults over 65.
A 2026 comparative review of leading NAD+ supplements reveals NR has stronger human data, while NMN marketing often outpaces clinical proof.
A completed RCT tests whether adding collagen peptides to standard calcium and vitamin D supplementation improves bone density and remodeling markers in women with osteopenia.
Baylor researchers investigated whether glutathione precursors glycine and NAC could reverse oxidative stress and mitochondrial dysfunction in COVID-19.
Expert reviews compare NMN and NR head-to-head. NMN edges out for muscle and sleep benefits; NR leads for neuroprotection.
